Clinical Trials Browser

Phase 2 × Withdrawn × Vancomycin × Clear all

NCT04025567 2020-03-16

Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) Oral

Phase 2 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular